- Committee for Medicinal Products for Human Use (CHMP)
-
The committee responsible for preparing the Agency’s opinions on all questions concerning medicines for human use, in accordance with Regulation (EC) No 726/2004. The CHMP plays a vital role in the marketing procedures for medicines in the EU and publishes a European public assessment report (EPAR) for every centrally authorised medicine that is granted market authorisation.